image_alt_text
5

Joerg Lahann, Ph.D.

AIMBE College of Fellows Class of 2011
For continuously advancing the frontiers of biomedical research by pioneering work on anisotropic particles, vapor-borne coatings, and switchable surfaces.

$2.38M to test nano-engineered brain cancer treatment in mice

Via University of Michigan | June 15, 2022

A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system

A new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.

With $2.38 million in funding from the National Institutes of Health, the medicine will soon be tested in mice at the University of Michigan.

Led by a nano-engineer and neuro-oncology researchers at U-M, the study is the first to test the two drugs together, packaged so that they can be delivered through the bloodstream rather than a hole in the skull. It builds on previous success eliminating cancer in seven out of eight mice by packaging just the immune drug in the protein that crosses the blood-brain barrier so that it could be delivered intravenously. The five-year survival rate for glioblastoma in humans is about 5%… Continue reading.